US Patent 9567386 Therapeutic uses of modified relaxin polypeptides
Patent 9567386 was granted and assigned to Ambrx on February, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9567386 Therapeutic uses of modified relaxin polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
